Effect of orally administered dextromethorphan on theophylline- and pentylenetetrazol-induced seizures in rats.
Dextromethorphan, widely used as an antitussive, has recently been shown to protect animals against maximal electroshock and excitatory amino acid (N-methyl-D-aspartate)-induced convulsions. Its protective efficacy against theophylline-induced seizures was determined in this investigation in view of the limited effectiveness of presently available anticonvulsants against this manifestation of serious theophylline intoxication. Rats were pretreated with an oral dose of dextromethorphan (50 mg/kg) or saline solution. Fifteen minutes later, the rats were infused intravenously with theophylline [approximately 11 mg/(kg.min)] until the onset of maximal seizures. Pretreatment with dextromethorphan was associated with a significant decrease in the concentrations of theophylline in the cerebrospinal fluid and serum at the pharmacologic endpoint. To further explore this unanticipated effect, a similar experiment was performed with the convulsant pentylenetetrazol (PTZ), which was infused at a rate of approximately 3.4 mg/(kg.min) until the onset of maximal seizures. Dextromethorphan-pretreated animals required a significantly larger dose of PTZ than did controls to produce the first myoclonic jerk, but a significantly smaller dose of the convulsant to produce maximal seizures. Serum and cerebrospinal fluid concentrations of PTZ at onset of maximal seizures were significantly lower in dextromethorphan-treated than in control animals. The proconvulsant activity of dextromethorphan with respect to theophylline-induced maximal seizures is similar to that of phenytoin, and is consistent with other pharmacologic evidence of such similarity.
Zhi
J G
JG
Department of Pharmaceutics, School of Pharmacy, State University of New York, Buffalo, Amherst.
Levy
G
G
D000284:Administration, Oral; D000818:Animals; D003915:Dextromethorphan / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D010433:Pentylenetetrazole / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D011292:Premedication; D051381:Rats; D011917:Rats, Inbred Lew; D012640:Seizures / Q000139:chemically induced / Q000517:prevention & control*; D013806:Theophylline / Q000009:adverse effects* / Q000037:antagonists & inhibitors
D003915:Dextromethorphan; D013806:Theophylline; D010433:Pentylenetetrazole